Imaging Tracer (68Ga-FAPi-46) for Solid Tumors or Blood Cancers
This study is looking at a new imaging tracer called 68Ga-FAPi-46 to see where it goes in the body and how much it collects in normal and cancer tissues. This is done using a PET/CT scan (Positron Emission Tomography/Computed Tomography), which is a special type of imaging. You might be able to join if you are 18 or older and have certain solid tumors or blood cancers, including anal, bladder, breast, or cervical cancer. The main goal is to understand how 68Ga-FAPi-46 spreads in the body. The study plans to enroll 30 people, but its current status is unclear.
- Study design
- This is an interventional study with a planned enrollment of 30 participants. It is designed to evaluate the biodistribution of 68Ga-FAPi-46.
- What's involved
- You would receive 68Ga-FAPi-46 intravenously (into a vein) and then undergo a PET/CT scan. You may also have an optional 18F-FDG PET/CT scan.
- Compensation
- Not stated in the trial record.
- Follow-up
- The biodistribution of 68Ga-FAPi-46 will be measured for up to 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jeremie Calais · PRINCIPAL_INVESTIGATOR · UCLA / Jonsson Comprehensive Cancer Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Biodistribution of gallium Ga 68 FAPi-46 (68Ga-FAPi-46)Up to 2 years
Will be evaluated in normal and cancer tissues by standardized uptake values to determine where and to which degree 68Ga-FAPi-46 accumulates in normal and cancer tissues.